FIELD: chemistry.
SUBSTANCE: invention relates to novel methods of producing 1,3-benzodioxole heterocyclic compounds of formula (I)
,
where R1 is selected from CHF2 and CF3, Q is selected from chlorine, bromine and fluorine.
EFFECT: compounds are effective as PDE4 inhibitors.
11 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTAGONISTS OF SOMATOSTATIN RECEPTOR SUBTYPE 5 (SSTR5) | 2014 |
|
RU2671958C2 |
| HETEROCYCLIC COMPOUNDS OF BENZODIOXOL OR BENZODIOXEPIN AS INHIBITORS OF PHOSPHODIESTERASES | 2011 |
|
RU2583787C2 |
| NEW PHOSPHODIESTERASE INHIBITORS | 2008 |
|
RU2495043C2 |
| METHOD FOR PRODUCING HETEROCYCLIC COMPOUNDS OF 1,3-BENZODIOXOL | 2016 |
|
RU2761337C2 |
| METHODS OF PREPARING 1,3-BENZODIOXOL HETEROCYCLIC COMPOUNDS | 2018 |
|
RU2814175C2 |
| SUBSTITUTED METHYLPHENYL KETONES SUITABLE FOR USE AS PDE4 INHIBITORS | 2007 |
|
RU2493149C2 |
| CONJUGATES FOR INTEGRIN ANTAGONIST TARGETED DELIVERY TO CELLS, EXPRESSING LFA-1 | 2013 |
|
RU2624732C2 |
| ANTISENSE NUCLEIC ACIDS | 2012 |
|
RU2619184C2 |
| TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
| N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
